An interventional study of Erector Spinae Plane Block and External Oblique Intercostal Plane Block and Lateral External Oblique Muscle Plane Block combination in Living Donor Nephrectomy, Postoperative Pain and Pain Management, sponsored by Istanbul Medipol University Hospital. Not yet recruiting. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Istanbul Medipol University Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Pain, Postoperative by Istanbul Medipol University Hospital — 4 open to participants now, 4 under way, none of them phase 3. Pain, Postoperative · Istanbul Medipol University Hospital.
Among the 13 studies in Pain, Postoperative by Istanbul Medipol University Hospital, this one is the 9th largest by planned enrollment, is one of 2 that started in 2026, is one of 12 with no phase, and was the 13th registered.
5,671 studies on the registry are indexed under Pain, Postoperative; 1,238 are open to participants now.
Browse Pain, Postoperative studies →4 of the 13 studies in Pain, Postoperative by Istanbul Medipol University Hospital are open now, in 1 country. Recruiting first, the newest first:
Istanbul Medipol University Hospital · Sites in Turkey
Ages 18–65
Istanbul Medipol University Hospital · Sites in Turkey
Ages 18–65
Istanbul Medipol University Hospital · Sites in Turkey
Ages 18+ · Healthy volunteers
By country, each count listing its studies:
Of the 678 Pain, Postoperative studies recruiting now, 240 (35%) set no upper age limit and 328 (48%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2015; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 70 is close to the median of 75 across 4,841 interventional studies indexed under Pain, Postoperative.
Median enrollment 90 across the 13 interventional studies. Of the 8 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Istanbul Medipol University Hospital is the lead sponsor of 368 studies on the registry; 48 are open to participants now.
1 of the studies in Pain, Postoperative by Istanbul Medipol University Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07790393Istanbul Medipol University HospitalAdductor Canal Block Versus Parasartorial Compartment Block for Pain Relief and Recovery After Arthroscopic Knee Surgery | 2027-06 |
Add it to your calendar (.ics) → With an account.
Among the 13 studies in Pain, Postoperative by Istanbul Medipol University Hospital, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Living kidney donors undergoing laparoscopic donor nephrectomy will be randomized to receive either an erector spinae plane block (ESPB) or a combination of external oblique intercostal (EOI) and lateral external oblique muscle plane (lateral EXOP) blocks at the end of surgery. The study aims to compare postoperative pain scores, opioid consumption, rescue analgesic requirement and postoperative nausea and vomiting between the two groups.
Laparoscopic living donor nephrectomy is associated with less postoperative pain than open surgery; however, trocar sites, the extraction incision and flank dissection can still cause substantial somatic and visceral pain. Results regarding the analgesic efficacy of ESPB in laparoscopic donor nephrectomy are conflicting, and sensory spread to the anterolateral abdominal wall after ESPB appears variable. The EOI block targets the lateral and anterior cutaneous branches of the T6-T10 intercostal nerves, and the lateral EXOP block targets the lateral cutaneous branches of T11-T12. As the trocar sites and the extraction incision are located on the anterolateral abdominal wall, we hypothesize that the combination of EOI and lateral EXOP blocks may provide more consistent analgesia than ESPB.
All donors will undergo transperitoneal laparoscopic donor nephrectomy, and the kidney will be extracted through the lower lateral trocar site as standard. Anesthesia will be induced with propofol, fentanyl and rocuronium and maintained with sevoflurane and remifentanil. Thirty minutes before the end of surgery, all patients will receive 1 g IV paracetamol, 100 mg IV tramadol and 8 mg IV ondansetron.
All blocks will be performed unilaterally on the surgical side under ultrasound guidance, after skin closure and before emergence from anesthesia, with the patient in the surgical lateral decubitus position. Each group will receive a total of 40 mL of 0.25% bupivacaine.
Group ESPB: the block will be performed at the T9 level, 2-3 cm lateral to the spinous process, with 40 mL of 0.25% bupivacaine injected deep to the erector spinae muscle.
Group EOI + lateral EXOP: the EOI block will be performed at the 6th rib level between the midclavicular and anterior axillary lines, with 20 mL of 0.25% bupivacaine injected between the external oblique and intercostal muscles. The lateral EXOP block will be performed on the mid-axillary line between the costal margin and the iliac crest, with 20 mL of 0.25% bupivacaine injected superficial to the external oblique muscle.
Postoperatively, all patients will receive 1 g IV paracetamol every 8 hours and fentanyl via IV patient-controlled analgesia (10 µg bolus, 10-minute lockout, no background infusion). Patients with NRS ≥4 despite PCA use will receive 0.5 mg/kg IV pethidine as rescue analgesia.
Because all blocks will be performed under general anesthesia, patients will be unaware of their group allocation. To maintain blinding, a standard dressing will be applied to all three potential block sites (paravertebral at T9, 6th rib level and lateral abdomen) in every patient. All postoperative assessments will be performed by an independent anesthesiologist who is not involved in block administration and is blinded to group allocation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Living kidney donors aged 18-65 years I-II Scheduled for elective pure transperitoneal laparoscopic donor nephrectomy Written
Exclusion Criteria:
Chronic pain or chronic opioid use Infection at the block site Allergy to local anesthetics Coagulopathy or anticoagulant use Body weight \<50 kg Pregnancy Inability to use the NRS or PCA device Refusal to participate
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Unilateral ultrasound-guided ESPB at T9 on the surgical side with 40 mL of 0.25% bupivacaine, performed at the end of surgery before emergence.
Procedure: Erector Spinae Plane Block · Drug: Standard Postoperative Analgesia
External oblique intercostal block and lateral external oblique muscle plane block combination will be applied. Unilateral ultrasound-guided EOI block at the 6th rib level (20 mL of 0.25% bupivacaine) and lateral EXOP block (20 mL of 0.25% bupivacaine) on the surgical side, performed at the end of surgery before emergence.
Procedure: External Oblique Intercostal Plane Block and Lateral External Oblique Muscle Plane Block combination · Drug: Standard Postoperative Analgesia
Unilateral ultrasound-guided erector spinae plane block performed on the surgical side at the T9 level after skin closure and before emergence from general anesthesia, with the patient in the lateral decubitus position. A linear probe will be placed 2-3 cm lateral to the spinous process in a parasagittal orientation. The needle will be advanced in-plane in a cranio-caudal direction until its tip lies between the erector spinae muscle and the transverse process. After hydrodissection with 5 mL of saline, 40 mL of 0.25% bupivacaine will be injected.
Also known as: ESPB, ESP Block
Unilateral ultrasound-guided blocks will be performed on the surgical side after skin closure and before emergence from general anesthesia. EOI block: the probe will be placed at the 6th rib level between the midclavicular and anterior axillary lines in a paramedian sagittal-oblique orientation, and 20 mL of 0.25% bupivacaine will be injected between the external oblique and intercostal muscles. Lateral EXOP block: the probe will be placed on the mid-axillary line between the costal margin and the iliac crest, and 20 mL of 0.25% bupivacaine will be injected superficial to the external oblique muscle. Correct needle tip position is confirmed with 5 mL of saline before each injection. Total volume: 40 mL of 0.25% bupivacaine.
Also known as: EOI block, Lateral EXOP block
All patients will receive 1 g IV paracetamol and 100 mg IV tramadol 30 minutes before the end of surgery. Postoperatively, 1 g IV paracetamol will be given every 8 hours, and fentanyl will be delivered via IV patient-controlled analgesia (10 µg bolus, 10-minute lockout, no background infusion). Patients with NRS ≥4 despite PCA will receive 0.5 mg/kg IV pethidine as rescue analgesia.
Also known as: Paracetamol, Tramadol, Fentanyl IV PCA
Pain score at 8th hour
Pain intensity at rest assessed with the Numeric Rating Scale (0 = no pain, 10 = worst imaginable pain)
Time frame: 8 hours after PACU admission
Cumulative fentanyl consumption
Total fentanyl given via IV PCA (µg).
Time frame: 0-24 hours postoperatively
Pain scores at rest and on coughing
Pain scores at rest and on coughing will be recorded based on NRS (0-10).
Time frame: 0, 2, 4, 8, 12 and 24 hours postoperatively.
Time to first rescue analgesic
Time from PACU admission to the first pethidine dose given for NRS ≥4.
Time frame: 0-24 hours postoperatively.
Incidence of postoperative nausea and vomiting.
Number of patients with any nausea or vomiting episode will be recorded.
Time frame: 0-24 hours postoperatively.
No study locations are listed for this record.
Plan to share: No — There is no plan to make individual participant data available
Start is estimated for Dec 2026; primary completion for Jan 2028, 13 months later.
Of 2,101 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 13 months is above that.
Counting every sponsor, half of 2,114 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istanbul Medipol University Hospital →